in an open study of 4-weeks duration , both an oral liquid concentrate formulation of loxapine hydrochloride ( loxitane c ) and capsules of loxapine succinate ( loxitane ) were administered to 11 acutely disturbed schizophrenic patients .
C0024057
loxapine
C0700779
loxitane